Cyclic GMP from the surrounding somatic cells regulates cyclic AMP and meiosis in the mouse oocyte.
Mammalian oocytes are arrested in meiotic prophase by an inhibitory signal from the surrounding somatic cells in the ovarian follicle. In response to luteinizing hormone (LH), which binds to receptors on the somatic cells, the oocyte proceeds to second metaphase, where it can be fertilized. Here we investigate how the somatic cells regulate the prophase-to-metaphase transition in the oocyte, and show that the inhibitory signal from the somatic cells is cGMP. Using FRET-based cyclic nucleotide sensors in follicle-enclosed mouse oocytes, we find that cGMP passes through gap junctions into the oocyte, where it inhibits the hydrolysis of cAMP by the phosphodiesterase PDE3A. This inhibition maintains a high concentration of cAMP and thus blocks meiotic progression. LH reverses the inhibitory signal by lowering cGMP levels in the somatic cells (from approximately 2 microM to approximately 80 nM at 1 hour after LH stimulation) and by closing gap junctions between the somatic cells. The resulting decrease in oocyte cGMP (from approximately 1 microM to approximately 40 nM) relieves the inhibition of PDE3A, increasing its activity by approximately 5-fold. This causes a decrease in oocyte cAMP (from approximately 700 nM to approximately 140 nM), leading to the resumption of meiosis.
Department of Cell Biology, University of Connecticut Health Center, Farmington, CT 06032, USA.
Rachael P
RP
Norris
William J
WJ
Ratzan
Marina
M
Freudzon
Lisa M
LM
Mehlmann
Judith
J
Krall
Matthew A
MA
Movsesian
Huanchen
H
Wang
Hengming
H
Ke
Viacheslav O
VO
Nikolaev
Laurinda A
LA
Jaffe
D000818:Animals; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism*; D006152:Cyclic GMP / Q000502:physiology*; D054684:Cyclic Nucleotide Phosphodiesterases, Type 3; D005260:Female; D017629:Gap Junctions / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007986:Luteinizing Hormone / Q000494:pharmacology / Q000502:physiology; D008540:Meiosis / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D009865:Oocytes / Q000187:drug effects / Q000502:physiology*; D006080:Ovarian Follicle / Q000187:drug effects / Q000502:physiology
D007986:Luteinizing Hormone; D000242:Cyclic AMP; D054684:Cyclic Nucleotide Phosphodiesterases, Type 3; C517287:PDE3A protein, human; D006152:Cyclic GMP